Three-photon microscopy (3PM) utilizing the near-infrared-III (NIR-III) window (1600–1840 nm) provides a pivotal tool for high-resolution visualization of cerebral vasculature in vivo, owing to its superior deep-tissue penetration capability. However, imaging quality is critically dependent on the performance of fluorescent probes. This study proposes a probe optimization design strategy evolving from mirror symmetry to centrosymmetry, leading to the synthesis of a highly symmetrical aggregation-induced emission (AIE) molecule, T4PQ. The centrosymmetric structure enables precise matching of donor (D)-acceptor (A) units, facilitating uniform electron cloud delocalization and directional charge transfer. This enhances exciton formation efficiency and suppresses non-radiative decay, thereby improving the fluorescence quantum yield. Furthermore, the highly symmetrical configuration significantly boosts the three-photon absorption cross-section by promoting electron delocalization and increasing the transition dipole moment, enabling stronger nonlinear optical responses under long-wavelength excitation. As a result, the designed T4PQ nanoparticles achieve optimized probe performance, combining an enhanced three-photon absorption cross-section, high fluorescence quantum yield, and excellent photostability. The corresponding nanoparticles (T4PQ NPs) exhibited a significantly enhanced three-photon absorption cross section, high fluorescence quantum yield, and excellent photostability. In murine in vivo experiments, T4PQ NPs achieved three-dimensional cerebrovascular imaging at a depth of 1785 µm and enabled real-time dynamic observation of hemodynamics in microvessels at a depth of 1006 µm, while demonstrating good biocompatibility. This research validates the advantage of centrosymmetric molecular structures in the design of deep-brain imaging probes, providing a high-performance tool for neurovascular research.



